FDA strikes neutral tone ahead of vaccine booster meeting

FDA strikes neutral tone ahead of vaccine booster meeting

Influential government advisers will debate Friday if there’s enough proof that a booster dose of Pfizer’s COVID-19 vaccine is safe and effective—the first step toward deciding which Americans need one and when.

Comments are closed.

New study identifies likely cause of Alzheimer’s disease
15 September 2021
One in 500 Americans has died from COVID-19
15 September 2021